ViroXis Lands $2,500,000 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1261 Silicon Drive San Antonio, TX 78249
  • Company Description
    The company develops botanical pharmaceuticals.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The capital will be used to advance development and commercialization of San Antonio, Texas-based ViroXis’ topical Albuterpenoid anti-viral treatment of skin warts.
  • M&A Terms
  • Venture Investor
    Texas Emerging Technology Fund

Trending on Xconomy